These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 16383013)
1. Abnormalities of chromatin in tumor cells. Drobic B; Dunn KL; Espino PS; Davie JR EXS; 2006; (96):25-47. PubMed ID: 16383013 [TBL] [Abstract][Full Text] [Related]
2. Chromatin organization and nuclear microenvironments in cancer cells. He S; Dunn KL; Espino PS; Drobic B; Li L; Yu J; Sun JM; Chen HY; Pritchard S; Davie JR J Cell Biochem; 2008 Aug; 104(6):2004-15. PubMed ID: 17668423 [TBL] [Abstract][Full Text] [Related]
3. Epigenetic modifications, chromatin distribution and TP53 transcription in a model of breast cancer progression. Santos GC; da Silva AP; Feldman L; Ventura GM; Vassetzky Y; de Moura Gallo CV J Cell Biochem; 2015 Apr; 116(4):533-41. PubMed ID: 25358520 [TBL] [Abstract][Full Text] [Related]
4. Histone modifications as a platform for cancer therapy. Espino PS; Drobic B; Dunn KL; Davie JR J Cell Biochem; 2005 Apr; 94(6):1088-102. PubMed ID: 15723344 [TBL] [Abstract][Full Text] [Related]
5. Altered primary chromatin structures and their implications in cancer development. Ferraro A Cell Oncol (Dordr); 2016 Jun; 39(3):195-210. PubMed ID: 27007278 [TBL] [Abstract][Full Text] [Related]
6. Epigenetics and MicroRNAs in Cancer. Ramassone A; Pagotto S; Veronese A; Visone R Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29401683 [TBL] [Abstract][Full Text] [Related]
7. Epigenetic tête-à-tête: the bilateral relationship between chromatin modifications and DNA methylation. D'Alessio AC; Szyf M Biochem Cell Biol; 2006 Aug; 84(4):463-76. PubMed ID: 16936820 [TBL] [Abstract][Full Text] [Related]
8. Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications. Sigalotti L; Fratta E; Coral S; Cortini E; Covre A; Nicolay HJ; Anzalone L; Pezzani L; Di Giacomo AM; Fonsatti E; Colizzi F; Altomonte M; Calabrò L; Maio M J Cell Physiol; 2007 Aug; 212(2):330-44. PubMed ID: 17458893 [TBL] [Abstract][Full Text] [Related]
10. Histone onco-modifications. Füllgrabe J; Kavanagh E; Joseph B Oncogene; 2011 Aug; 30(31):3391-403. PubMed ID: 21516126 [TBL] [Abstract][Full Text] [Related]
11. DNA methylation, chromatin inheritance, and cancer. Rountree MR; Bachman KE; Herman JG; Baylin SB Oncogene; 2001 May; 20(24):3156-65. PubMed ID: 11420732 [TBL] [Abstract][Full Text] [Related]
12. DNA methylation and histone modifications in patients with cancer: potential prognostic and therapeutic targets. Herranz M; Esteller M Methods Mol Biol; 2007; 361():25-62. PubMed ID: 17172706 [TBL] [Abstract][Full Text] [Related]
13. From histones to RNA: role of methylation in cancer. Xhemalce B Brief Funct Genomics; 2013 May; 12(3):244-53. PubMed ID: 23313959 [TBL] [Abstract][Full Text] [Related]
14. Histone modifications and cancer. Sawan C; Herceg Z Adv Genet; 2010; 70():57-85. PubMed ID: 20920745 [TBL] [Abstract][Full Text] [Related]
15. Intranuclear and higher-order chromatin organization of the major histone gene cluster in breast cancer. Fritz AJ; Ghule PN; Boyd JR; Tye CE; Page NA; Hong D; Shirley DJ; Weinheimer AS; Barutcu AR; Gerrard DL; Frietze S; van Wijnen AJ; Zaidi SK; Imbalzano AN; Lian JB; Stein JL; Stein GS J Cell Physiol; 2018 Feb; 233(2):1278-1290. PubMed ID: 28504305 [TBL] [Abstract][Full Text] [Related]
16. [Chromatin epigenetic modifications in cancer generation]. Arenas-Huertero F; Recillas-Targa F Gac Med Mex; 2002; 138(6):547-55. PubMed ID: 12532619 [TBL] [Abstract][Full Text] [Related]
17. Epigenetic interplays between DNA demethylation and histone methylation for protecting oncogenesis. Furuya K; Ikura M; Ikura T J Biochem; 2019 Apr; 165(4):297-299. PubMed ID: 30605533 [TBL] [Abstract][Full Text] [Related]
18. The roles of DNA, RNA and histone methylation in ageing and cancer. Michalak EM; Burr ML; Bannister AJ; Dawson MA Nat Rev Mol Cell Biol; 2019 Oct; 20(10):573-589. PubMed ID: 31270442 [TBL] [Abstract][Full Text] [Related]
19. DNA methylation alterations in multiple myeloma as a model for epigenetic changes in cancer. Sharma A; Heuck CJ; Fazzari MJ; Mehta J; Singhal S; Greally JM; Verma A Wiley Interdiscip Rev Syst Biol Med; 2010; 2(6):654-69. PubMed ID: 20890963 [TBL] [Abstract][Full Text] [Related]
20. Molecular Pathways: Metabolic Control of Histone Methylation and Gene Expression in Cancer. Tran TQ; Lowman XH; Kong M Clin Cancer Res; 2017 Aug; 23(15):4004-4009. PubMed ID: 28404599 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]